Tag Archives: LDN
Research: Potential therapeutic benefit of Low Dose Naltrexone in ME/CFS
Potential Therapeutic Benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome: role of Transient Receptor Potential Melastatin 3 Ion channels in pathophysiology and treatment, by Helene Cabanas, Katsuhiko Muraki, Natalie Eaton-Fitch, Donald Ross Staines and Sonya Marshall-Gradisnik in … Continue reading
Low-dose naltrexone in the treatment of ME/CFS
Low-dose naltrexone in the treatment of myalgic encephalomyelitis/ chronic fatigue syndrome (ME/CFS), by Olli Polo, Pia Pesonen, Essi Tuominen in Fatigue: Biomedicine, Health & Behavior Nov 19, 2019 [doi/full/10.1080/21641846.2019.1692770] Research abstract: Background: Myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) is … Continue reading
Biovista identifies potential drugs for ME/CFS
Solve ME/CFS Initiative Press Release: Results of Biovista Work Released In 2012, the Solve ME/CFS Initiative—under its former organization as the CFIDS Association of America—funded Biovista Inc., a private drug development services company, to identify potential drugs that might be … Continue reading
Anti-inflammatory drugs and CFS/ME
Richard N. Podell M.D., MPH discusses the implications of Japanese research which found inflammation in the brain on the prohealth website: For most people with Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (CFS/ME) central nervous system function is abnormal. However, we don’t understand the … Continue reading
